Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
While today's medications may be becoming more affordable, newer therapies are expected to enter the market that may offer greater efficacy , but come with higher costs
As consequences of polymorphism of MTHFR , reduction of MTHFR enzymatic activity would cause impaired methylation as well as deficiency of folate
Injections tend to cost more upfront due to higher doses, supplies, and sometimes provider involvement
Clinical Trial of a Leucotriene B4 Receptor Antagonist, BIIL 284, in Patients With Rheumatoid Arthritis
US$ 25.42
US$ 23.61
US$ 26.89
.png)
US$ 21.50
US$ 21.79
US$ 28.72
US$ 26.84
US$ 25.96
US$ 29.85
US$ 25.32
US$ 9396.00
Sold : Login>>
